412
Views
10
CrossRef citations to date
0
Altmetric
Letter to the Editor

Complete sustained regression of extensive psoriasis with cetuximab combination chemotherapy

Pages 592-593 | Received 17 May 2004, Accepted 08 Jun 2004, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (9)

Masutaka Furue, Kazuhisa Furue, Gaku Tsuji & Takeshi Nakahara. (2020) Interleukin-17A and Keratinocytes in Psoriasis. International Journal of Molecular Sciences 21:4, pages 1275.
Crossref
L. Goepel, A. Jacobi, M. Augustin & M.A. Radtke. (2018) Rapid improvement of psoriasis in a patient with lung cancer after treatment with erlotinib. Journal of the European Academy of Dermatology and Venereology 32:8, pages e311-e313.
Crossref
Fenlai Tan, Guiqun Yang, Yanping Wang, Haibo Chen, Bo Yu, He Li, Jing Guo, Xiaoling Huang, Yifang Deng, Pengxia Yu & Lieming Ding. (2018) Icotinib inhibits EGFR signaling and alleviates psoriasis-like symptoms in animal models. Biomedicine & Pharmacotherapy 98, pages 399-405.
Crossref
Ken Okamoto. (2015) Cetuximab and panitumumab in a patient with colon cancer and concomitant chronic skin disease: A potential beneficial effect on psoriasis vulgaris. World Journal of Gastroenterology 21:12, pages 3746.
Crossref
M. Kamaria, C. R. Shea, R. K. Chin, E. E. Cohen, R. Maggiore & D. Bolotin. (2014) Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab. Clinical and Experimental Dermatology 39:5, pages 604-607.
Crossref
Donna Petch, Rosaleen J. Anderson, Anne Cunningham, Suja E. George, David E. Hibbs, Ran Liu, Simon P. Mackay, Andrew Paul, David A.P. Small & Paul W. Groundwater. (2012) Design and synthesis of EGFR dimerization inhibitors and evaluation of their potential in the treatment of psoriasis. Bioorganic & Medicinal Chemistry 20:19, pages 5901-5914.
Crossref
Albert Mas-Vidal, Pablo Coto-Segura, Cristina Galache-Osuna & Jorge Santos-Juanes. (2011) Psoriasis induced by cetuximab: A paradoxical adverse effect. Australasian Journal of Dermatology 52:1, pages 56-58.
Crossref
Julie A. Wolfram, Doina Diaconu, Denise A. Hatala, Jessica Rastegar, Dorothy A. Knutsen, Abigail Lowther, David Askew, Anita C. Gilliam, Thomas S. McCormick & Nicole L. Ward. (2009) Keratinocyte but Not Endothelial Cell-Specific Overexpression of Tie2 Leads to the Development of Psoriasis. The American Journal of Pathology 174:4, pages 1443-1458.
Crossref
Domingo Bodet, Ramón Bartralot, Jordi Mollet, Cristina Heras & Vicente García-Patos. (2006) Aportación a las erupciones acneiformes por inhibidores del receptor del factor de crecimiento epidérmico. Actas Dermo-Sifiliográficas 97:2, pages 148-149.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.